BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31290618)

  • 21. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
    Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
    Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
    Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
    Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
    Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram.
    Wang S; Deng Y; Yu X; Zhang XW; Huo CL; Sun ZG; Chang H
    Sci Rep; 2021 Jul; 11(1):13814. PubMed ID: 34226605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma.
    Hu H; Han XK; Long XR; Fan J; Yan ZP; Wang JH; Liu R
    Oncotarget; 2016 Sep; 7(36):58302-58314. PubMed ID: 27506942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
    Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
    Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
    He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
    Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.
    Feng LH; Dong H; Lau WY; Yu H; Zhu YY; Zhao Y; Lin YX; Chen J; Wu MC; Cong WM
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):293-303. PubMed ID: 27743138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma.
    Chai Y; Li K; Zhang C; Chen S; Ma K
    BMC Cancer; 2019 May; 19(1):497. PubMed ID: 31133001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.
    Kao WY; Su CW; Chiou YY; Chiu NC; Liu CA; Fang KC; Huo TI; Huang YH; Chang CC; Hou MC; Lin HC; Wu JC
    Radiology; 2017 Nov; 285(2):670-680. PubMed ID: 28562211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
    J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation.
    Tan W; Sun W; Li X; Zhao L; Wang C; Zang A; Kong X
    J Cancer Res Ther; 2018 Jan; 14(1):84-89. PubMed ID: 29516965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma.
    Hsu CY; Liu PH; Hsia CY; Lee YH; Nagaria TS; Lee RC; Ho SY; Hou MC; Huo TI
    Sci Rep; 2017 Aug; 7(1):7914. PubMed ID: 28801646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma.
    Ha Y; Han S; Shim JH; Ko GY; Yoon HK; Sung KB; Lee D; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
    J Vasc Interv Radiol; 2015 Aug; 26(8):1093-1101.e1. PubMed ID: 26077020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomogram of the Barcelona Clinic Liver Cancer system for individual prognostic prediction in hepatocellular carcinoma.
    Hsu CY; Liu PH; Hsia CY; Lee YH; Al Juboori A; Lee RC; Lin HC; Huo TI
    Liver Int; 2016 Oct; 36(10):1498-506. PubMed ID: 26972815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.
    Hsu CY; Liu PH; Ho SY; Hsia CY; Kudaravalli P; Lee YH; Chiou YY; Tsai YJ; Huang YH; Huo TI
    BMC Cancer; 2018 Mar; 18(1):289. PubMed ID: 29540157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study.
    Hsu CY; Liu PH; Hsia CY; Lee YH; Nagaria TS; Lee RC; Lin HC; Huo TI
    Ann Surg Oncol; 2016 Mar; 23(3):994-1002. PubMed ID: 26487000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.